img
Simultaneous determination of albendazole sulfoxide and praziquantel from PLGA nanoparticles and validation of new HPLC method   
Yazarlar
Yakup Gültekin
Selçuk Üniversitesi, Türkiye
Naile Öztürk
İnönü Üniversitesi, Türkiye
Ayhan Filazi
Türkiye
Prof. Dr. Ahmet DENİZ Prof. Dr. Ahmet DENİZ
Türkiye
Çağla Korkmaz
Türkiye
Esra Pezik
Türkiye
Gözde Barın
Türkiye
İmran Vural
Hacettepe Üniversitesi, Türkiye
Özet
A simple, rapid and reproducible HPLC method has been developed and validated for the quantification of albendazole sulfoxide (ALBSOX) and praziquantel (PRZ), which can coexist in various dosage forms. Chromatographic separation was performed in gradient mode using a mobile phase consisting of an InertSustain® C18 column (150 × 4.6 mm, 5 μm) and acetonitrile: water (v/v) at a flow rate of 1.0 mL/min. The active substance peaks were well separated and detected by a DAD detector at 217 nm. The HPLC method was linear for ALBSOX and PRZ in the concentration range of 0.1-50 μg/mL. Limit of detection (LOD) was found to be 0.01 μg/mL for ALBSOX and 0.009 μg/mL for PRZ. The limit of quantification (LOQ) was found to be 0.03 μg/mL for ALBSOX and 0.027 μg/mL for PRZ. The developed HPLC method was validated based on ICH guidelines for specificity, linearity, system suitability, precision and accuracy. The method was applied for simultaneous quantification and characterization studies of ALBSOX and PRA in PLGA nanoparticles.
Anahtar Kelimeler
Makale Türü Özgün Makale
Makale Alt Türü ESCI dergilerinde yayımlanan tam makale
Dergi Adı Journal of Research in Pharmacy
Dergi ISSN 2630-6344
Dergi Tarandığı Indeksler ESCI
Makale Dili İngilizce
Basım Tarihi 07-2022
Cilt No 26
Sayı 6
Sayfalar 1608 / 1618
Doi Numarası 10.29228/jrp.252
Makale Linki http://dx.doi.org/10.29228/jrp.252